Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–9. https://doi.org/10.1053/j.gastro.2017.04.022.
Article
PubMed
Google Scholar
Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med. 1991;324(15):1043–8. https://doi.org/10.1056/NEJM199104113241507.
Article
CAS
PubMed
Google Scholar
Caselli M, Alvisi V. Helicobacter pylori and peptic-ulcer disease. Lancet. 2002;359(9321):1943–4. https://doi.org/10.1016/S0140-6736(02)08746-9.
Article
PubMed
Google Scholar
Henriksson AE, Edman AC, Held M, Wadström T. Helicobacter pylori and acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol. 1995;7(8):769–71.
CAS
PubMed
Google Scholar
Ishaq S, Nunn L. Helicobacter pylori and gastric cancer: a state of the art review. Gastroenterol Hepatol Bed Bench. 2015;8(Suppl 1):S6–14.
PubMed
PubMed Central
Google Scholar
Wotherspoon AC. Gastric MALT lymphoma and helicobacter pylori. Yale J Biol Med. 1996;69(1):61–8.
CAS
PubMed
PubMed Central
Google Scholar
Kim BJ, Kim HS, Jang HJ, Kim JH. Helicobacter pylori eradication in idiopathic thrombocytopenic Purpura: a meta-analysis of randomized trials. Gastroenterol Res Pract. 2018;2018:1–8. https://doi.org/10.1155/2018/6090878.
Article
Google Scholar
Monzón H, Forné M, Esteve M, Rosinach M, Loras C, Espinós JC, et al. Helicobacter pylori infection as a cause of iron deficiency anaemia of unknown origin. World J Gastroenterol. 2013;19(26):4166–71. https://doi.org/10.3748/wjg.v19.i26.4166.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China: A Randomized Controlled Trial | Gastroenterology | JAMA | JAMA Network. https://jamanetwork.com/journals/jama/fullarticle/197985. Accessed 4 Jul 2020.
Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in helicobacter pylori: a recent literature review. World J Methodol. 2015;5(3):164–74. https://doi.org/10.5662/wjm.v5.i3.164.
Article
PubMed
PubMed Central
Google Scholar
Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 2018;155:1372–82 e17.
Article
Google Scholar
Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30. https://doi.org/10.1136/gutjnl-2016-312288.
Article
CAS
PubMed
Google Scholar
Cheha KM, Dib SOA, Alhalabi MM. Pilot study: comparing efficacy of 14-day triple therapy clarithromycin versus levofloxacin on eradication of helicobacter pylori infection in Syrian population single-center experience. Avicenna J Med. 2018;8(1):14–7. https://doi.org/10.4103/ajm.AJM_70_17.
Article
PubMed
PubMed Central
Google Scholar
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of helicobacter pylori infection. Am J Gastroenterol. 2017;112. https://journals.lww.com/ajg/Fulltext/2017/02000/ACG_Clinical_Guideline__Treatment_of_Helicobacter.12.aspx(2):212–39. https://doi.org/10.1038/ajg.2016.563.
Article
PubMed
Google Scholar
Niv Y. Doxycycline in eradication therapy of helicobacter pylori--a systematic review and meta-analysis. Digestion. 2016;93(2):167–73. https://doi.org/10.1159/000443683.
Article
CAS
PubMed
Google Scholar
Berrutti M, Pellicano R, Astegiano M, Smedile A, Saracco G, Morgando A, et al. Helicobacter pylori eradication: metronidazole or tinidazole? Data from Turin, Italy. Minerva Gastroenterol Dietol. 2008;54(4):355–8.
CAS
PubMed
Google Scholar
Moshkowitz M, Konikoff FM, Peled Y, Brill S, Hallak A, Tiomny E, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther. 1996;10(6):1015–9. https://doi.org/10.1046/j.1365-2036.1996.96268000.x.
Article
CAS
PubMed
Google Scholar
Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ. 1998;317(7159):647–50. https://doi.org/10.1136/bmj.317.7159.647.
Article
CAS
PubMed
PubMed Central
Google Scholar
Satoh K, Kimura K, Taniguchi Y, Kihira K, Takimoto T, Saifuku K, et al. Biopsy sites suitable for the diagnosis of helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol. 1998;93(4):569–73. https://doi.org/10.1111/j.1572-0241.1998.166_b.x.
Article
CAS
PubMed
Google Scholar
Lee JY, Kim N. Diagnosis of helicobacter pylori by invasive test: histology. Ann Transl Med. 2015;3. https://doi.org/10.3978/j.issn.2305-5839.2014.11.03.
Veijola L, Myllyluoma E, Korpela R, Rautelin H. Stool antigen tests in the diagnosis of helicobacter pylori infection before and after eradication therapy. World J Gastroenterol. 2005;11(46):7340–4. https://doi.org/10.3748/wjg.v11.i46.7340.
Article
PubMed
PubMed Central
Google Scholar
Basu PP, Rayapudi K, Pacana T, Shah NJ, Krishnaswamy N, Flynn M. A randomized study comparing levofloxacin, omeprazole, Nitazoxanide, and doxycycline versus triple therapy for the eradication of helicobacter pylori. Am J Gastroenterol. 2011;106(11):1970–5. https://doi.org/10.1038/ajg.2011.306.
Article
CAS
PubMed
PubMed Central
Google Scholar
Borody TJ, George LL, Brandl S, Andrews P, Lenne J, Moore-Jones D, et al. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy. Scand J Gastroenterol. 1992;27(4):281–4. https://doi.org/10.3109/00365529209000075.
Article
CAS
PubMed
Google Scholar
Wang Z, Wu S. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of helicobacter pylori: an open-label control study in Chinese patients. Singap Med J. 2012;53(4):273–6.
Google Scholar
Federico A, Nardone G, Gravina AG, Iovene MR, Miranda A, Compare D, et al. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterology. 2012;143:55–61 e1; quize e13–14.
Article
CAS
Google Scholar
Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009;1(1):51–4.
PubMed
PubMed Central
Google Scholar
Gupta K, Attri J, Singh A, Kaur H, Kaur G. Basic concepts for sample size calculation: critical step for any clinical trials! Saudi J Anaesth. 2016;10(3):328–31. https://doi.org/10.4103/1658-354X.174918.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res. 2010;1:67.
PubMed
PubMed Central
Google Scholar
Eshraghian A. Epidemiology of helicobacter pylori infection among the healthy population in Iran and countries of the eastern Mediterranean region: a systematic review of prevalence and risk factors. World J Gastroenterol. 2014;20(46):17618–25. https://doi.org/10.3748/wjg.v20.i46.17618.
Article
PubMed
PubMed Central
Google Scholar
Kuo Y-T, Liou J-M, El-Omar EM, Wu J-Y, Leow AHR, Goh KL, et al. Primary antibiotic resistance in helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(10):707–15. https://doi.org/10.1016/S2468-1253(17)30219-4.
Article
PubMed
Google Scholar
Graham DY, Lu H, Yamaoka Y. A report card to grade helicobacter pylori therapy. Helicobacter. 2007;12(4):275–8. https://doi.org/10.1111/j.1523-5378.2007.00518.x.
Article
PubMed
Google Scholar
Essa AS, Kramer JR, Graham DY, Treiber G. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing “concomitant therapy” versus triple therapy for Helicobacter pylori eradication. Centre for Reviews and Dissemination (UK); 2009. https://www.ncbi.nlm.nih.gov/books/NBK77292/. Accessed 4 Sep 2020.
Yuan Y, Ford AC, Khan KJ, Gisbert JP, Forman D, Leontiadis GI, Tse F, Calvet X, Fallone C, Fischbach L, Oderda G, Bazzoli F, Moayyedi P. Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev. 2013;(12):CD008337. https://doi.org/10.1002/14651858.CD008337.pub2.
Haddadi M-H, Negahdari B, Asadolahi R, Bazargani A. Helicobacter pylori antibiotic resistance and correlation with cagA motifs and homB gene. Postgrad Med. 2020;:1–4l.
Levy SB, Star L, Kupferberg ED. The misuse of antibiotice. Medical Ethics (Burlington, Mass). 2004;11:5–8.
Google Scholar
Schroeck JL, Ruh CA, Sellick JA, Ott MC, Mattappallil A, Mergenhagen KA. Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections. Antimicrob Agents Chemother. 2015;59(7):3848–52. https://doi.org/10.1128/AAC.00652-15.
Article
CAS
PubMed
PubMed Central
Google Scholar
Giono-Cerezo S, Santos-Preciado JI, Morfin-Otero MDR, Torres-Lopez FJ, Alcantar-Curiel MD. Antimicrobial resistance. Its importance and efforts to control it. Gac Med Mex. 2020;156(2):171–8. https://doi.org/10.24875/GMM.M20000358.
Article
PubMed
Google Scholar
Chokshi A, Sifri Z, Cennimo D, Horng H. Global contributors to antibiotic resistance. J Global Infect Dis. 2019;11(1):36–42. https://doi.org/10.4103/jgid.jgid_110_18.
Article
Google Scholar
Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother. 2002;49(6):897–903. https://doi.org/10.1093/jac/dkf046.
Article
CAS
PubMed
Google Scholar
Grob PR. Antibiotic prescribing practices and patient compliance in the community. Scand J Infect Dis Suppl. 1992;83:7–14.
CAS
PubMed
Google Scholar
Eells SJ, Nguyen M, Jung J, Macias-Gil R, May L, Miller LG. Relationship between adherence to Oral antibiotics and Postdischarge clinical outcomes among patients hospitalized with Staphylococcus aureus skin infections. Antimicrob Agents Chemother. 2016;60(5):2941–8. https://doi.org/10.1128/AAC.02626-15.
Article
CAS
PubMed
PubMed Central
Google Scholar